Neurokine Pharmaceuticals Inc. - FORM 10-Q/A - XML - IDEA: XBRL DOCUMENT - December 21, 2011



Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R2.htm
EXCEL - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Neurokine Pharmaceuticals Inc.R9.htm
10-Q/A - FORM 10-Q/A - Neurokine Pharmaceuticals Inc.neurokineform10qaxbrlq2july3.htm
v2.4.0.6
Payables and Accruals
3 Months Ended
Jul. 31, 2011
Payables and Accruals [Abstract]  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

Note 4.  Note Payable

(a) On April 6, 2011, the Company issued a note payable with a non-related party for $150,000.  The note is unsecured, due interest at 24% per annum, due on Junly 6, 2011.  On July 6, 2011, the note was repaid. 

(b) On July 4, 2011, the Company issued a note payable with a non-related party for $85,000.  The note is unsecured, due interest at 24% per annum, and due on October 4, 2011.

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by Neurokine Pharmaceuticals Inc. and has no official or unofficial affiliation with Neurokine Pharmaceuticals Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.